Method and device for enhanced composition delivery
Methods and devices that provide enhanced delivery of a composition to a body region of a patient utilizing radiofrequency energy include directing a first electrode and a second electrode coupled to a radiofrequency energy source to a location proximate to the body region. Radiofrequency energy is provided in modulated pulses from the radiofrequency energy source to the body region from at least one of the first electrode and the second electrode to provide a delivery condition configured to enhance delivery of the composition. The composition is delivered proximate to the body region using a composition delivery element. Devices for enhance composition delivery are also disclosed.
1. A method for enhanced delivery of a composition to a body region of a patient utilizing radiofrequency energy, the method comprising:
directing a first electrode and a second electrode coupled to a radiofrequency energy source to a location proximate to the body region;
providing the radiofrequency energy in modulated pulses from the radiofrequency energy source to the body region from at least one of the first electrode and the second electrode to provide a delivery condition configured to enhance delivery of the composition, wherein the providing the radiofrequency energy has a first adjustment that shortens a duration of the modulated pulses to a micro or nanosecond range that induces deeper imbedding of the composition into the body region and a second adjustment to lengthen a duration of the modulated pulse greater than the micro or nanosecond range; and
delivering the composition proximate to the body region using a composition delivery element.
2. The method of claim 1 , wherein the composition is a therapeutic agent or a pharmaceutical compound.
3. The method of claim 2 , wherein the therapeutic agent or pharmaceutical compound is a thrombolytic agent, a fibrinolytic enzyme, a thrombin inhibitor, an antiplatelet agent, an anticoagulant, an anti-restenotic agent, or an anti-cancer agent.
4. The method of claim 1 , wherein the body region is a vessel, graft, or duct.
5. The method of claim 4 , wherein the body region comprises an occlusion located therein.
6. The method of claim 1 , wherein the body region is a gland, an organ, or a tumor located in the body region.
7. The method of claim 1 , wherein the composition delivery element is a balloon, a stent, microbubbles, ribs, or a catheter.
8. The method of claim 7 , wherein the balloon, the ribs, or the catheter is expandable.
9. The method of claim 7 , wherein the composition delivery element has a surface coated or imbedded with the composition.
10. The method of claim 7 , wherein the composition delivery element is microbubbles filled with the composition.
11. The method of claim 1 , wherein the delivery condition is one of cavitation, microjets, shockwaves, electrical stimulation, or a chemical reaction.
12. The method of claim 11 , wherein the delivery condition is a shockwave having an instantaneous magnitude between 0.1 MPa to 20 MPa.
13. The method of claim 11 , wherein the delivery condition is at least one region of cavitation bubbles having a diameter of between 1 um and 10 mm.
14. The method of claim 1 , wherein the delivering the radiofrequency energy provides for prolonged delivery and imbedding of the composition within the body region.
15. The method of claim 1 wherein further comprising measuring a signal associated with the body region and adjusting the provided radiofrequency energy based on the measured signal wherein the measuring and the adjusting further comprises:
determining one or more impedance measurements based on the delivery of the radiofrequency energy; and
optimizing the delivery of the radiofrequency based on the one or more impedance measurements.
16. The method of claim 1 , wherein the first electrode and the second electrode have a dielectric barrier to implement low-intensity plasma discharge.
17. The method of claim 1 , wherein the modulated pulses have a pulse width between about 0.05 to about 500 microseconds.
18. The method of claim 1 , wherein the modulated pulses have a pulse width between about 500 microseconds and 1 second.
19. The method of claim 1 , wherein the modulated pulses have a pulse width less than 0.05 microseconds.
20. The method of claim 1 , wherein the modulated pulses of the radiofrequency energy are gated using an ECG or another waveform signal obtained from the body.
21. The method of claim 1 , wherein the modulated pulses are grouped into bursts having a burst width between 100 ms to 1 s and an interval between each burst between 1 ms to 100 ms.
22. The method of claim 1 , wherein the radiofrequency energy is between 400V to 4000V.
23. The method of claim 1 , wherein the radiofrequency energy is less than 400V.
24. The method of claim 1 , wherein an incident intensity of the radiofrequency energy is between about 0.1 to 5 Joules per square millimeter.
25. The method of claim 1 further comprising delivering the radiofrequency energy until electrical limit is met.
26. The method of claim 25 , wherein the electrical limit is less than 100 Ohms.
27. The method of claim 1 , wherein the providing the radiofrequency energy provides a mechanical force to enhance diffusion of the composition into the body region to enhance the delivery of the composition.
28. The method of claim 1 , wherein the providing the radiofrequency energy causes vasodilation, increased cell permeability, or reversible electroporation to enhance the delivery of the composition.
29. The method of claim 1 , wherein the composition is delivered to the body region prior to the delivery of the radiofrequency energy.
30. The method of claim 1 , wherein the first electrode and the second electrode are delivered on a single longitudinal member.
31. The method of claim 30 , wherein the single longitudinal member is a catheter or a guidewire.
32. The method of claim 1 , wherein the first electrode is delivered on a first longitudinal member and the second electrode is delivered on a second longitudinal member.
33. The method of claim 32 , wherein the first longitudinal member and the second longitudinal member are independent, non-overlapping guidewires or catheters.
34. The method of claim 32 , wherein the delivering comprises delivering the first longitudinal member and the second longitudinal member to the body region in the same direction.
35. The method of claim 32 , wherein the delivering comprises delivering the first longitudinal member and the second longitudinal member to the body region from opposite directions.
36. The method of claim 1 , wherein one of the first electrode or the second electrode is located on a patch placed outside the body region.
37. The method of claim 1 , further comprising:
providing a third electrode located on a patch placed outside the body region, wherein the third electrode is electrically coupled to the first electrode and the second electrode.